Neonatologist-performed Lung Ultrasound in the Delivery Room

May 13, 2024 updated by: Medical University of Graz

Neonatologist-performed Lung Ultrasound During Immediate Transition After Birth to Predict the Need for Respiratory Support Persisting More Than 1 Hour - a Pilot Study

The objective of this study is to evaluate the role of the neonatologist-performed lung ultrasound (NPLUS) during immediate transition after birth of late preterm and full-term neonates using the lung ultrasound score to predict the need of respiratory support persisting more than 1 hour after birth.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Lung ultrasound is an emerging clinical tool to assess the lung in a dynamic way. Recently, the focus has been on establishing lung ultrasound in the neonatal intensive care unit (NICU) as a point-of care application.

Neonates born by a Caesarean section are particularly prone to have an altered adaption to extrauterine life. Especially in the first hours after birth, respiratory distress syndromes (RDS) may occur due to delayed lung fluid clearance after birth.

While acute RDS in the first hours after birth may be a self-limiting disorder and therefore a benign condition, it remains difficult to identify neonates in need for further respiratory support at the NICU. Admission to the NICU not only causes parental stress but also contributes to additional healthcare costs.

There is emerging evidence that NPLUS is a reliable tool to differentiate between the causes leading to RDS in neonates. Using a neonatologist performed lung ultrasound score for the early identification of neonates in need of respiratory support persisting more than 1 hour would be therefore highly advantageous.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Late preterm neonates (born between 34 0/7 and 36 6/7 weeks of gestation), and full-term neonates (born later than 36 6/7 weeks of gestation) delivered by Caesarean section

Description

Inclusion Criteria:

  • Late preterm neonates (born between 34 0/7 and 36 6/7 weeks of gestation) and full-term neonates (born later than 36 6/7 weeks of gestation) delivered by Caesarean section
  • Presence of any sign of respiratory distress (defined as tachypnoea/ dyspnoea, grunting, flaring of the nostrils or chest retractions)
  • Written informed consent obtained from the parents prior to birth.

Exclusion Criteria:

  • Presence of cardiopulmonary malformations
  • Patients with pneumothorax diagnosed by neonatologist-performed lung ultrasound

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
need of respiratory support > 60 min after birth
Group comprises neonates in need of further respiratory support more than 60 minutes after birth.
lung ultrasound conducted in min 5, 15, 30, 60 min after birth in late preterm and term infants
need of respiratory support < 60 min after birth
Group comprises neonates that show any signs of respiratory distress in the first 60 minutes, but do not need respiratory support more than 60 minutes after birth.
lung ultrasound conducted in min 5, 15, 30, 60 min after birth in late preterm and term infants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of the change in lung ultrasound score according to Rodriguez-Fanjul et al. 2020
Time Frame: 60 minutes for all scans, 2-4 min per scan.

Score determined by neonatologist-performed lung ultrasound conducted at 5, 15, 30 and 60 minutes after birth. The lung ultrasound score will be calculated by performing bilateral longitudinal scans of the chest on the midclavicular, anterior, and posterior axillary line.

For every scan a score is given ranging from 0 (for normal lung aeration) up to 3 (describing extended consolidations in the lung).

60 minutes for all scans, 2-4 min per scan.
The need for respiratory support persisting more than 1 hour after birth
Time Frame: 60 minutes
binary - yes/ no
60 minutes
Admission to the Neonatal Intensive Care Unit
Time Frame: 60 minutes
binary - yes/ no
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of respiratory support
Time Frame: 60 minutes
in minutes
60 minutes
Mode of respiratory support
Time Frame: 60 minutes
non-invasive versus invasive ventilation
60 minutes
Routinely obtained capillary blood gas analysis of the newborn
Time Frame: 60 minutes
pCO2, pO2, pH, BE, HCO3, lactate, glucose
60 minutes
Routinely obtained monitoring parameters- SpO2
Time Frame: 60 minutes
arterial oxygen saturation (SpO2)
60 minutes
Routinely obtained monitoring parameters- heart rate
Time Frame: 60 minutes
heart rate in beats per minute (either by pulse oximetry or electrocardiography)
60 minutes
Routinely obtained monitoring parameters- cerebral oxygen saturation
Time Frame: 60 minutes
cerebral oxygen saturation (assessed by near-infrared spectroscopy)
60 minutes
SpO2/FiO2
Time Frame: 60 minutes
fraction of inspired oxygen ratio to O2 supply
60 minutes
pH of the umbilical artery
Time Frame: 15 minutes
in numbers
15 minutes
APGAR score
Time Frame: 10 minutes
Score ranges from 0 to 10, higher score indicates a better outcome
10 minutes
Number of Participants with Presence of pregnancy risk factors
Time Frame: 10 minutes
including intra-amniotic infection, and premature rupture of the membranes
10 minutes
Number of Participants with Prenatal corticosteroids
Time Frame: 10 minutes
binary - yes/ no
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bernhard Schwaberger, MD PhD, Division of Neonatology, Medical University of Graz, Austria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

May 31, 2025

Study Completion (Estimated)

May 31, 2025

Study Registration Dates

First Submitted

April 25, 2024

First Submitted That Met QC Criteria

May 6, 2024

First Posted (Actual)

May 10, 2024

Study Record Updates

Last Update Posted (Actual)

May 16, 2024

Last Update Submitted That Met QC Criteria

May 13, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 36-150 ex 23/24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neonatal Disease

Clinical Trials on Neonatologist-performed lung ultrasound

Subscribe